At the end of 20 weeks, serum levels of IL1β, IL6, IL8, and IL10 in the COPD group were significantly higher than in the control group (P < 0.01), while those in the BYF group were significantly lower than the COPD group (P < 0.01). Here, IL10 is linked to chronic obstructive pulmonary disease.